Grants & Projects per year
Fingerprint
Dive into the research topics where Hal A Skopicki is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
FASTR II TRIAL: Fluid Management of Acute Decompensated Heart Failure Subjects Treated with Reprieve System
Singer, A. (PI) & Skopicki, H. A. (CoPI)
09/2/25 → …
Project: Research
-
MHI: A Phase III, Double-blind, Randomized Placebo-Controlled Study to Evaluate the Effects of Dalcetrapib on Cardiovasclar (CV) Risk in a Genetically Defined Population with a Recent Acute Coronary Syndrome (ACS): The DAL-302 Trial
Rahman, T. (PI), Chen, O. (CoPI), Farooq, K. (CoPI), Skopicki, H. A. (CoPI), Albertus, P. (CoPI) & Ibtida, I. (CoPI)
06/30/25 → …
Project: Research
-
Duke Clinical: A Phase 2, Randomized, Double-blind, Placebo-controlled, Proof-of-concept Trial for OPC-131461 in Patients who Have Been Hospitalized for Worsening Heart Failure and Have Laboratory Evidence of Incomplete Decongestion Follow
Skopicki, H. A. (PI), Goldschmidt, M. (CoPI), Jang, K. H. (CoPI) & Tam, E. (CoPI)
06/25/25 → …
Project: Research
-
A Propective, Multi-Center, Open Label, Randomized Control Clinical Trial Evaluating the Safety and Efficacy of the Cordella Pulmonary Artery Sensor System in New York Heart Association (NYHA) Class II-III Heart Failure Patients (PROACTIVE-
Skopicki, H. A. (PI), Goldschmidt, M. (CoPI), Lawson, W. (CoPI), Parikh, P. B. (CoPI) & Tam, E. (CoPI)
09/3/24 → …
Project: Research
-
A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Amyloid Depleter ALXN2220 in Adult Participants with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Skopicki, H. A. (PI), Riquelme, L. A. (CoPI), Borriello, C. (CoPI) & Reilly, P. (CoPI)
Alexion Pharmaceuticals Incorporated
03/29/24 → 11/14/26
Project: Research
-
Detecting Occlusion Myocardial Infarction with an AI-Powered ECG Model: A Retrospective Cohort Study †
Hellerman, M. B., Wang, C., Zhang, D. T., Kalogeropoulos, A. P. & Skopicki, H. A., Apr 2026, In: Journal of Personalized Medicine. 16, 4, 174.Research output: Contribution to journal › Article › peer-review
Open Access -
Cathepsin-D and outcomes in peripartum cardiomyopathy: Results from IPAC
for the IPAC Investigators, Jan 2025, In: American Heart Journal Plus: Cardiology Research and Practice. 49, 100489.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Lipoprotein(a) as a Predictor of Cardiovascular Risk in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review
Mojahedi, A., Chen, O., Skopicki, H. A., Rahman, T. & Sadeghian, A., Sep 2025, In: Reviews in Cardiovascular Medicine. 26, 9, 42784.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations -
Remote Hemodynamic Monitoring for Heart Failure: In or On?
Kransdorf, E. P. & Skopicki, H. A., Aug 2025, In: JACC: Heart Failure. 13, 8, 102507.Research output: Contribution to journal › Editorial
-
The Role of Cystatin C in the Prediction of Contrast-Induced Acute Kidney Injury Following Coronary Procedures: A Systematic Review
Mojahedi, A., Kalogeropoulos, A. P., Chen, O. & Skopicki, H., Jul 2025, In: Reviews in Cardiovascular Medicine. 26, 7, 36643.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations